Connect with us


Dr Peter Grinspoon joins first global cannabis clinic



Dr Peter Grinspoon - the new chief medical director at Q2 clinics

US cannabis expert Dr Peter Grinspoon has joined the first international chain of clinics to support access to cannabis care and education across the globe.

International medical cannabis clinic, Q2 Clinics has announced the appointment of Dr. Peter Grinspoon, M.D. as chief medical director. 

Dr. Grinspoon is a primary care physician and cannabis specialist at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School

He is a certified Health and Wellness Coach as well as a board member of the advocacy group Doctors for Cannabis Regulation.

With more than two decades of experience, Dr. Grinspoon will lead Q2 Clinic’s international network of doctors giving his advice on medical matters, developing clinical protocols and quality assurance and bringing his expertise on the field of Endocannabinology to ensure that the company provides the best possible care to patients.

Q2 Clinics is the first international chain of medical cannabis clinics, founded with the objective of constructing a global network of high-end health practices based on the use of medicinal cannabis.

Karan Madan, CEO of Q2 Clinic, said: “I am very pleased to welcome Peter to Q2 Clinic as Medical Director. As a lifelong advocate and internationally-recognized expert in medical cannabis, he will be invaluable to help us guide our medical practice around the world.”

Dr Grinspoon is a widely recognised expert on cannabis science and drug policy and has appeared on US TV shows including NPR’s All Things Considered, NBC Nightly News, C-SPAN’s Washington Journal, Fox and Friends and Fox News.

He is also the author of memoir Free Refills: A Doctor Confronts His Addiction, which was optioned for television production by MarVista Entertainment and was the expert witness in the successful citizens’ 2019 lawsuit against the Massachusetts “Vape Ban”.

He is a contributing editor to Harvard Health Publications, where his writings have reached millions of readers and have been widely referenced in the national media and have been cited in congressional testimony.

“I am delighted to be joining Q2 Clinic’s international team of talented professionals,” Dr Grinspoon commented.

“Q2’s mission of spreading the highest quality medical cannabis care and education across the globe is one that I wholeheartedly support.”

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.